Hongxuan Technology's pharmaceutical APIs & intermediates production phase I project

Summary: Between 26 Aug. and 8 Sept., Hongxuan Technology publicised an EIA report of its 5,000 t/a pharmaceutical APIs & pharmaceutical intermediates production phase I project (including vitamin D3, OME chlorides, etc.). On 26 Aug.-8 Sept., Lanzhou...

Vitamins China E-News 202109

www.cnchemicals.com